Results 31 to 40 of about 59,572 (271)

Is disorganized schizophrenia a predictor of treatment resistance? Evidence from an observational study

open access: yesBrazilian Journal of Psychiatry, 2013
Objective: To investigate whether inpatients with disorganized schizophrenia are more resistant to treatment. Method: Eighty-five inpatients were assessed at admission and at discharge for schizophrenia subtype, symptom severity, and treatment ...
Bruno Bertolucci Ortiz   +4 more
doaj   +1 more source

Combination of clozapine, cariprazine and fluoxetine in treatment-resistant schizophrenia patient with prominent negative symptoms: A Case report

open access: yesEuropean Psychiatry, 2022
Introduction Despite pharmacological advances in the treatment of schizophrenia, significant number of patients are still treatment-resistant. Clozapine is recommended as first-line treatment for treatment-resistant schizophrenia (TRS) in guidelines ...
I. Everte, A. Pamše-Romāne, M. Taube
doaj   +1 more source

Strategies in clozapine-resistant schizophrenia: A literature review

open access: yesJournal of Mental Health and Human Behaviour, 2016
Treatment resistance to what is often deemed the last line of schizophrenia treatment, clozapine, is a burgeoning problem in psychiatric practice, with estimates of clozapine resistance standing at 40–70% of the treated population.
Ganesh Kundadak Kudva   +1 more
doaj   +1 more source

Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia

open access: yesBMC Psychiatry, 2023
Antipsychotic drugs are the first line of treatment in schizophrenia; although antipsychotic responses indicate a wide interindividual variety in patients with schizophrenia.
Narges Taheri   +4 more
doaj   +1 more source

Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics [PDF]

open access: yes, 2013
There is a critical need for mapping early metabolic changes in schizophrenia to capture failures in regulation of biochemical pathways and networks.
Buckley, P   +45 more
core   +1 more source

Combined use of clozapine and cariprazine in treatment-resistant schizophrenia, is it a good choice?

open access: yesEuropean Psychiatry, 2021
Introduction Treatment-resistant schizophrenia (TRS) affects 30% of people with a diagnosis of schizophrenia, and is defined as nonresponse to at least two trials of antipsychotic medication of adequate dose and duration. Clozapine is the only evidence-
H. Becerra Darriba
doaj   +1 more source

Thyroid function test abnormalities in treatment-resistant schizophrenia

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Objective: The relationship between thyroid dysfunction and mood disorders is well recognized. Thyroid function abnormalities are bad prognostic factors in mood disorders, and augmentation with thyroid hormone has therapeutic efficacy in treatment ...
Ertac Sertac Orsel   +4 more
doaj  

A Case Report: Treatment Resistant Schizophrenia [PDF]

open access: yesDüşünen Adam Psikiyatri ve Nörolojik Bilimler Dergisi, 2004
Clinicians define resistance to treatment of schizophrenia, as a failure including functional and psyhcosocial dimensions despite adequate dosage, duration and treatment consistency.
Gamze Sönmez   +5 more
doaj  

A Genome-Wide Investigation of SNPs and CNVs in Schizophrenia [PDF]

open access: yes, 2009
We report a genome-wide assessment of single nucleotide polymorphisms (SNPs) and copy number variants (CNVs) in schizophrenia. We investigated SNPs using 871 patients and 863 controls, following up the top hits in four independent cohorts comprising 1 ...
Rujescu, D.   +218 more
core   +1 more source

Home - About - Disclaimer - Privacy